The Vitamin Shoppe ‘s Whole Health Rx is expanding its support for GLP-1 users.

Hims — the next gen telehealth startup that made waves by taking the eye contact out of erectile dysfunction treatment. Of ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Sucralose increases hypothalamic activity linked to hunger more than sugar or water, especially in women and people with ...

ADM’s partnership with Asahi Group lays the foundation for the ingredient supplier to innovate in digestive and women's ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

A new study found that a popular zero-calorie sugar substitute disrupts regions of the brain responsible for regulating ...

For years, the Healthy at Every Size (HAES) movement dominated conversations about weight and health, arguing body fat wasn’t ...